StimGuard launches OAB neurostim trial
StimGuard said today it enrolled the 1st patient in a clinical trial of its StimGuard miniature implantable device designed to treat urinary incontinence resulting from refractory overactive bladder syndrome.
The Fort Lauderdale, Fla.-based company’s system is implanted at the tibial nerve through a needle-sized introducer and uses wireless technology to stimulate the nerve and treat the symptoms of overactive bladder.
“If successfully trialed, the StimGuard technology would allow neuromodulation to be offered to patients in an office setting, which has never been the case before for a permanent, long-term tre...
Source: Mass Device - December 15, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Neuromodulation/Neurostimulation StimGuard Source Type: news
Siteless: The Future of Clinical Trials?
This article is extracted fromTrends in Clinical Data& Technology. To download the magazine, clickhere.Related Content: The Patient Data Gold RushMeeting the Information Needs of PatientsTurning Clinical Trial Recruitment on its HeadConnecting with Patients via Compelling ContentPrimary Event: Data Quality and Technology in Clinical Trials USAPr écis: Clinical trials are moving out of the clinic and into patients ’ own homes.Premium`: Freemium`: Channels: ClinicalTags: Clinical DataClinical DevelopmentClinical Trial RecruitmentClinical Trial SoftwareClinical TrialsChannelimage:&nbs...
Source: EyeForPharma - November 17, 2016 Category: Pharmaceuticals Authors: Danielle Barron Source Type: news
Is Overactive Bladder Real?
(MedPage Today) -- Marketing or medicine: which is it? (Source: MedPage Today Urology)
Source: MedPage Today Urology - November 2, 2016 Category: Urology & Nephrology Source Type: news
Botox May Top Neuromodulation in Overactive Bladder Botox May Top Neuromodulation in Overactive Bladder
Episodes of urinary urgency were slightly lower after onabotulinumtoxinA injections, but the treatment led to more urinary tract infections and self-catheterizations in a randomized controlled trial.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 6, 2016 Category: Consumer Health News Tags: Urology News Source Type: news
Eisai launches Uritos tablets to treat overactive bladder in Thailand
Pharmaceutical company Eisai has launched Uritos tablets (imidafenacin) to treat overactive bladder (OAB), in Thailand. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - October 4, 2016 Category: Pharmaceuticals Source Type: news
Bluewind Medical wins CE Mark for Vivendi mini-neurostim pain implant
Neurostim developer Bluewind Medical said today it won CE Mark approval in the European Union for its Vivendi neurostimulation device designed to treat peripheral neuropathic pain.
The newly cleared neurostim device is 90% smaller than ‘typical’ neurostimulators on the market, the Israeli company said, and is designed to be implanted in close proximity to the Tibial nerve so it can apply electrical stimulation to the nerve to ease or mask pain.
“This new treatment paradigm, transforms the way patients are treated today, relieves them from the need for Opioid or other pharmacological treatments and allows...
Source: Mass Device - September 7, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Neuromodulation/Neurostimulation Pain Management Regulatory/Compliance Bluewind Medical Source Type: news
Cipla gets USFDA nod for overactive bladder treating drug
"We have received final approval for ANDA for Darifenacin extended-release tablets, 7.5 mg and 15mg, from USFDA," a company statement said here. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - September 2, 2016 Category: Pharmaceuticals Source Type: news
"It's A Scandal" -Daryl Hall on Doctors Denying Chronic Lyme
Growing up a musically-obsessed child in the 80's, Daryl Hall was one of my biggest inspirations. A masterful, inventive songwriter with an ocean of soul, he set me on the path to being an artist, to never waste a word, and to sing because I mean it.
With six number ones and five additional top ten hits throughout the 70's and 80's Daryl Hall and John Oates are the number one duo in music history. Still at the top of his game at 69 years old, Daryl has won legions of new fans with his hit MTV Live show Live From Daryl's House.
In February of 2015, at my very sickest from chronic Lyme and Bartonella, after it was missed b...
Source: Science - The Huffington Post - July 22, 2016 Category: Science Source Type: news
Vensica Medical Completes $500,000 Finance Round
MISGAV, Israel, July 19, 2016 -- (Healthcare Sales & Marketing Network) -- Vensica Medical, a portfolio company of Trendlines Medical, announced the completion of a financing round of US$500,000 from a private foreign investor. Vensica is developing a ne... Devices, Drug Delivery, Urology, Venture CapitalVensica Medical, overactive bladder, Botox (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2016 Category: Pharmaceuticals Source Type: news
Darin Hammers Appointed President And CEO Of Cogentix Medical, Inc.
MINNEAPOLIS, July 12, 2016 -- (Healthcare Sales & Marketing Network) -- Cogentix Medical, Inc. (CGNT), a global medical device company with innovative and proprietary products serving urology and airway management markets, today announced that Darin Hamme... Devices, Urology, PersonnelCogentix Medical, EndoSheath, overactive bladder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 12, 2016 Category: Pharmaceuticals Source Type: news
Researchers identify bacterial infection as a possible cause of bladder condition
A research team has identified bacterial infection as a possible cause of Overactive Bladder Syndrome (OAB). OAB is a condition where the bladder muscle spontaneously contracts before the bladder is full. In the USA, it is ranked in the top 10 of common chronic conditions, competing with both diabetes and depression, with a reported prevalence of up to 31-42% in the adult population. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 7, 2016 Category: Science Source Type: news
Understanding how chemical changes in the brain affect Alzheimer's disease
A new study is helping to explain why the long-term use of common anticholinergic drugs used to treat conditions like allergies and overactive bladder lead to an increased risk of developing dementia later in life. The study used mouse models to show that long-term suppression of the neurotransmitter acetylcholine -- a target for anticholinergic drugs -- results in dementia-like changes in the brain. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - June 22, 2016 Category: Science Source Type: news
Understanding how chemical changes in the brain affect Alzheimer's disease
(University of Western Ontario) A new study from Western University is helping to explain why the long-term use of common anticholinergic drugs used to treat conditions like allergies and overactive bladder lead to an increased risk of developing dementia later in life. The study used mouse models to show that long-term suppression of the neurotransmitter acetylcholine -- a target for anticholinergic drugs -- results in dementia-like changes in the brain. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 22, 2016 Category: Global & Universal Source Type: news
Axonics launches post-market sacral neuromod OAB study
Axonics Modulation Technologies said today it launched the Relax-OAB 65-patient post-market clinical follow-up study of its SNM system designed to treat overactive bladder.
The SNM rechargeable neuromod system is designed to treat overactive bladder, urinary retention and fecal incontinence through sacral nerve stimulation, the Irvine, Calif.-based company said.
Axonics touted the 1st implants and enrollments in the study, which took place at London’s National Hospital for Neurology and Neurosurgery and the Netherlands’ Maastricht University Medical Centre.
“This miniaturized rechargeable SNM System repre...
Source: Mass Device - June 20, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Neuromodulation/Neurostimulation Urology Axonics Modulation Technologies Source Type: news
5 Health Symptoms Men Should Watch Out For
When was the last time you went in for your annual checkup? In honor of Men's Health Month, I want to discuss the importance of paying attention to your body and visiting your primary care physician on a regular basis. If you're healthy, a yearly visit might be sufficient but if you have a family history of any disease, have a pre-existing condition, or have suffered an injury, you may have to follow up with a doctor or specialist more often. A doctor's visit is as much a part of a healthy lifestyle as clean eating and consistent exercise. If you have any issues or symptoms, especially any of the below, don't be afraid to ...
Source: Healthy Living - The Huffington Post - June 16, 2016 Category: Consumer Health News Source Type: news
